ArticleThe European respiratory journal2018
Article in The European respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lung cancer screening with low-dose CT: definition of positive, indeterminate, and negative screen results. A nodule management recommendation from the European Society of Thoracic Imaging.European radiology · 2026Guideline
- A predictive nomogram for two-year growth of CT-indeterminate small pulmonary nodules.European radiology · 2022Trial
- Aggressiveness-guided nodule management for lung cancer screening in Europe-justification for follow-up intervals and definition of growth.European radiology · 2026Review
- Growth dynamics of lung nodules: implications for classification in lung cancer screening.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
- Factors influencing the outcome of volumetry tools for pulmonary nodule analysis: a systematic review and attempted meta-analysis.Insights into imaging · 2023Review
- Indeterminate pulmonary subsolid nodules in patients with no history of cancer: growing prediction, CT pattern, and pathological diagnosis.Diagnostic and interventional radiology (Ankara, Turkey) · 2022Article
- Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.Clinical lung cancer · 2022Article
- European lung cancer screening: valuable trial evidence for optimal practice implementation.The British journal of radiology · 2022Article
- Dynamic Observation of Lung Nodules on Chest CT Before Diagnosis of Early Lung Cancer.Frontiers in oncology · 2022Article
- Similarities between pandemics and cancer in growth and risk models.Scientific reports · 2021Article
- Duration of lead time in screening for lung cancer.BMC pulmonary medicine · 2021Review
- The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice.Journal of thoracic disease · 2020Article
- Unravelling complexities of the subsolid pulmonary nodule-detection, characterization, natural history, monitoring and (future) patient management.Journal of thoracic disease · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current pulmonary nodule management guidelines are based on nodule volume doubling time, which assumes exponential growth behaviour. However, this is a theory that has never been validated
Indexed as
Identifiers
29650547What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.